Algo version: 0.98b
Telix Pharmaceuticals is listed at the ASX Exchange
Telix Pharmaceuticals [TLX.AX]
ASX Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Telix Pharmaceuticals stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Telix Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $1.305, you would have made a profit of $16.44 per share or 1 259.39%

Yes, the average daily trading liquidity for Telix Pharmaceuticals is $1.61 million. You should therefore be able to get in and out of your positions relatively fast.

Telix Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.37, the company's ability to pay off the debt is good. The company has a very low net profit margin of 1.04%, which is challenging.

We have calculated the inflation risk for Telix Pharmaceuticals to be low [0.2 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.